Check out the PYC Road Show Investor Presentation
22 March 2010.
.........
Page 34
There are now 20 prospective pharma partners in the pipeline and 3 more Big Pharma deals in late stage negotiation.
Page 25
Future Estimates
Discovery Pharma Partnerships
Value per Drug Target US$
Upfront licence fee $500K
Contract Discovery 3-4 FTE's/yr $750K-$1M
Milestone Payments $1M-$100M
Royalties usually single digit %
Preclinical Licenses of Internal Drug Leads
Upfront Fees
Milestone Payment 7 to 8 figures
Royalties
Large Strategic Alliance Around Disease Areas
eg. Ablynx/Bl 1.8 Billion
Galapagos/ Merck 1 Billion
Morphosis/ Novartis >$600M
..........
What would one Large Strategic Alliance do to the PYC SP ?
roadshow investor presentation
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $489.9M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 16707 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 6708 | 1 |
View Market Depth
| Last trade - 09.41am 26/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |
Day chart unavailable